Sinotherapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,661	4,517	4,978	7,593	-	-
Market Cap Growth	4.74%	-9.25%	-34.45%	-	-	-
Enterprise Value	3,895	3,769	4,194	6,771	-	-
Last Close Price	10.38	10.00	10.83	16.44	-	-
PE Ratio	49.00	35.37	81.50	81.71	-	-
PS Ratio	9.70	8.83	16.60	30.67	-	-
PB Ratio	3.56	3.55	4.11	6.45	-	-
P/TBV Ratio	3.66	3.66	4.28	6.74	-	-
P/FCF Ratio	136.35	127.97	-	-	-	-
P/OCF Ratio	38.89	34.69	384.14	103.76	-	-
EV/Sales Ratio	8.11	7.37	13.99	27.35	-	-
EV/EBITDA Ratio	38.36	27.36	62.24	80.84	-	-
EV/EBIT Ratio	44.89	31.55	94.67	116.33	-	-
EV/FCF Ratio	113.95	106.79	-	-	-	-
Debt / Equity Ratio	0	0	0	0.00	0.01	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.02	0.04	-
Debt / FCF Ratio	0.00	0	-	-	0.03	-
Asset Turnover	0.33	0.36	0.22	0.23	0.39	0.51
Inventory Turnover	2.69	2.63	2.34	1.96	1.71	2.29
Quick Ratio	10.84	8.19	9.13	9.76	6.21	3.37
Current Ratio	12.21	9.46	10.49	10.59	6.91	3.83
Return on Equity (ROE)	7.75%	10.29%	5.12%	9.87%	21.29%	24.97%
Return on Assets (ROA)	3.76%	5.31%	2.06%	3.31%	7.41%	12.26%
Return on Invested Capital (ROIC)	14.20%	21.46%	9.84%	19.49%	52.09%	71.98%
Return on Capital Employed (ROCE)	6.30%	8.80%	3.50%	4.70%	12.30%	20.60%
Earnings Yield	2.12%	2.83%	1.23%	1.22%	-	-
FCF Yield	0.73%	0.78%	-0.52%	-1.36%	-	-
Dividend Yield	0.49%	0.62%	0.38%	0.38%	-	-
Payout Ratio	29.27%	21.83%	46.02%	-	-	-
Buyback Yield / Dilution	0.93%	2.92%	-11.22%	-3.32%	-0.21%	-
Total Shareholder Return	1.42%	3.54%	-10.84%	-2.94%	-0.21%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.